| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.2 | 6e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.19 | 6e-05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |